中的遗传-表观遗传相互作用:途径,生物标志物和表观基因组向疗法
Andra-Giorgiana Zaruha1, Patricia Codreanu1, Mădălin-Codruț Coman1
1Department of Medical Genetics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Epigenomes
|February 20, 2026
概括
表观遗传因素通过改变基因表达和神经元功能,显著影响发育. 了解这些表观遗传机制为精准医学和新型治疗策略开辟了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 是一种复杂的神经系统疾病,具有重要的遗传成分.
- 表观遗传机制在病发病过程中起着至关重要的作用,与遗传因素相互作用.
研究的目的:
- 综合当前关于的遗传和表观遗传因素之间的相互作用的知识.
- 探索表观遗传失调如何促进神经元刺激性和网络可塑性.
- 讨论针对治疗的表观遗传修饰的新兴治疗策略.
主要方法:
- 审查当前关于的遗传和表观遗传机制的文献.
- 分析染色体重塑,基因组修饰,DNA甲基化和转录调节的交集.
- 检查参与的表观遗传调节的信号通路 (mTOR,PI3K-AKT,GABAergic).
主要成果:
- 表观遗传失调,包括染色体重塑和DNA甲基化,有助于神经元过敏性和中的网络可塑性.
- 受环境因素影响的基因突变和表观遗传修饰之间的相互作用塑造了现象.
- 新兴的表观遗传疗法,如HDAC和DNMT抑制剂,对精准医学有很大的前景.
结论:
- 对的遗传和表观遗传层的全面理解对于开发有效的治疗方法至关重要.
- 表观遗传修饰为的治疗干预提供了新的标.
- 多omics方法和表观基因组编辑具有个性化管理的潜力.
相关概念视频
Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
Epigenetic Regulation
34.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
Pharmacogenomics: Identification of New Drug Targets
29
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29


